Js Capital Management LLC Repligen Corp Transaction History

Js Capital Management LLC

  • $199 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$165.87 - $220.95 $414,675 - $552,375
-2,500 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$180.37 - $226.26 $450,925 - $565,650
2,500 New
2,500 $486,000
Q3 2020

Nov 16, 2020
SELL
$122.51 - $158.27 $931,076 - $1.2 Million
-7,600 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$94.33 - $140.48 $716,908 - $1.07 Million
7,600 New
7,600 $939,000

Others Institutions Holding RGEN

# of Institutions
477
Shares Held
54.9M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.66B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Js Capital Management LLC Portfolio

Follow Js Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Js Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Js Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email